In the shadow of the threat from Tehran: the global trial for lung cancer is underway

Patients with an aggressive tumor in the lungs will be the first to receive a new biological treatment from Novartis, which harnesses the immune system to eliminate cancer cells • Prof. Ido Wolf: "tremendous hope for patients" • At the same time, the tensions with Tehran and the reforms in the USA threaten the status of local research